(Q24235874)

1

0 references

Wendy Wang

2

0 references

Carla Morley

3

0 references

Amir Soltani

4

0 references

Richard Wood-Baker

Cochrane Database of Systematic Reviews

5

0 references

publication date

5 October 2011

0 references

published in

0 references

cites work

Systemic glucocorticoids in severe exacerbations of COPD.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

A PEACE-ful solution to COPD exacerbations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

A step‐wise application of methylprednisolone versus dexamethasone in the treatment of acute exacerbations of COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

Airways inflammation and treatment during acute exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

Impact of COPD exacerbations on patient-centered outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

COPD exacerbations .1: Epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

Prevalence and predictors of vertebral fracture in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

Chronic obstructive pulmonary disease in the United Kingdom: trends in mortality, morbidity, and smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

Exacerbations and progression of disease in asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

Toward a consensus definition for COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

Oral corticosteroids for stable chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

Economic analysis of the Confronting COPD survey: an overview of results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

Fracture risk with intermittent high-dose oral glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

Analysing Data and Undertaking Meta-Analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

Chronic obstructive pulmonary disease: an overview of pathology and pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

7 January 2021

The results of a randomized controlled trial of hydrocortisone in acute exacerbation of COPD

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

7 January 2021

New strains of bacteria and exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

7 January 2021

Corticosteroids contribute to muscle weakness in chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

7 January 2021

Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

7 January 2021

Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

7 January 2021

Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006897.PUB2

7 January 2021

10.1002/14651858.CD006897.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

21975757

1 reference

Consolidated OpenCitations Corpus – April 2017